Agenda
07:00 – 09:00 | Breakfast | ||
Session I | |||
08:50 – 09:00 | Welcoming Remarks | ||
09:00 – 10:30 |
ORAL PRESENTATIONS OF ORIGINAL RESEARCH WORK AND OF CLINICAL CASESMinh-Duc Ngo, Sabrina Hoa Randomized Controlled Trial in limited Cutaneous Systemic Sclerosis: a Systematic Literature Review.Michele Stanciu, Marie Hudson Chained to a Diagnosis?Michael Aw, Inés Colmegna Case Report: Parvovirus B19 Associated Large-vessel Vasculitis in an Immunocompromised Patient.Claire Adams, Brett Thombs Patient Engagement in Rheumatic Research: State of the Evidence.Wen Qi, Say Yan Yuen Musculoskeletal Ultrasound in Systemic Lupus Erythematosus (SLE): A Scoping Review.Évelyne Vinet Overweight and Obesity are Key Modifiable Risk Factors for Adverse Outcomes in Systemic Lupus Erythematosus (SLE) Pregnancies.At the end of this session, participants will be better able to:
|
||
10:30 – 11:00 | Break | ||
Session II | |||
11:00 – 12:00 |
Maladie de Sjögren : de la pathophysiologie au traitement.Xavier Mariette, MD, PhD At the end of this session, participants will be better able to:
|
||
12:00 – 13:00 | Lunch | ||
Session III | |||
13:00 – 13:30 |
ORAL PRESENTATIONS OF ORIGINAL RESEARCH WORK AND OF CLINICAL CASESÉvelyne Gendron Alcohol Consumption is Associated with Spinal Radiographic Progression in Axial Spondyloarthritis.Laëtitia Michou Identification de variants génétiques rares dans les formes familiales de la Maladie de Dupuytren.At the end of this session, participants will be better able to:
|
||
13:30 – 14:30 |
La place de l’arthroplastie dans le traitement des pathologies dégénératives de l’épaule.Stéphane Pelet, MD, PhD, FRCSC At the end of this session, participants will be better able to:
|
||
Session IV | |||
14:30 – 15:30 |
Grossesses lupiquesÉvelyne Vinet, MD, PhD At the end of this session, participants will be better able to:
|
||
15:30 – 16:00 | Break | ||
16:00 – 17:00 | Poster Session
Sophie Hu, Brett Thombs Differential Item Functioning on the 8-itemPatient Health Questionnaire by Disease Sub-type, Language, Sex and Age among People with Systemic Sclerosis. A Scleroderma Patient-centered Network (SPIN) Cohort Study.Cassidy Dal Santo, Brett Thombs Adaptation and Validation of Measures to Assess Coping with Fatigue in Scleroderma: Two Scleroderma Patient-centered Intervention Network (SPIN) Cohort Studies.Elsa-Lynn Nassar, Brett Thombs Update from a Living Systematic Review of the Prevalence of Mood and Anxiety Disorders and Factors Associated with Symptoms in People with Systemic Sclerosis.Amy Qi, Inés Colmegna Hip-hop : A Case of Transient Osteoporosis of Both Hips.Mathieu Rousseau, Sabrina Hoa. Le rôle des analyses quantitatives des scans thoraciques dans la prédiction de la progression de la maladie pulmonaire interstitielle légère associée à la sclérodermie.Sabrina Hoa Distinct Systemic Sclerosis Phenotypes Related to Race/Ethnicity: an Opportunity to Personalize Care?Natasha Leblanc, Arielle Mendel Antibiotic Prophylaxis during Treatment of ANCA-associated Vasculitis with Rituximab: Data from a Canadian Multicenter Cohort.Kaitlin Nuechterlein, Évelyne Vinet Placental Abnormalities in Systemic Lupus Erythematosus (SLE): Novel Markers for Adverse Pregancy Outcomes. |
||
19:00 |
Dinner & Awards |
07:00 – 09:00 | Breakfast | ||
Session V | |||
9:00 – 9:30 |
ORAL PRESENTATIONS OF ORIGINAL RESEARCH WORK AND OF CLINICAL CASESMarianela Brizio, Inés Colmegna Systemic Sclerosis Mesenchymal Stromal Cells Exhibit Senescence and Profibrotic Features with Preserved Immunomodulatory and Anti-fibrotic Function.Olivia Stein , Sasha Bernatsky The Patient Perspective in Systemic Lupus Erythematosus (SLE) Trials: A Focus Group StudyAt the end of this session, participants will be better able to:
|
||
9:30 – 10:30 |
L’histoire de la déplétion des lymphocytes B dans les maladies auto-immunes : du rituximab aux CAR-T cells.
À la fin de cette session, les participants sauront mieux :
|
||
10:30 – 11:00 | Break | ||
Session VI | |||
11:00 – 12:00 |
Brush and Floss: why oral health matters in rheumatology
À la fin de cette session, les participants sauront mieux :
|
||
12:00 | Closing Remarks |